All In Biotech

Drug Trial Radar · NCT00412893

Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis

A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi.

Last checked: Nov 19, 2026Latest source record: Dec 10, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 527 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

527

Actual

Start

Mar 7, 2007

Primary completion

Mar 28, 2013

Study completion Mar 28, 2013

Sponsor

Lead sponsor
Astellas Pharma IncAstellas (ALPMY)
Sponsor type
Industry
Collaborators
Basilea Pharmaceutica International Ltd
First posted
Dec 19, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to compare the efficacy and safety of isavuconazole versus voriconazole in the treatment of patients with invasive aspergillosis.

Conditions

  • Aspergillosis
  • Invasive Fungal Infection

Interventions

  • IsavuconazoleDrug

    Loading doses were administered as IV infusion and maintenance doses were administered as IV infusion or oral (capsules).

  • VoriconazoleDrug

    Loading doses were administered as IV infusion and maintenance doses were administered as IV infusion or oral (capsules).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. All-cause Mortality Through Day 42Time frame: Through Day 42

Locations

107 sites in 26 countries. Site status is shown where the registry gives one.

  • University of Alabama

    Birmingham, Alabama

  • University of California at San Francisco

    San Francisco, California

  • University of Chicago, Division of Infectious Diseases

    Chicago, Illinois

  • Indiana BMT

    Springfield, Illinois

  • Springfield Clinic LLP

    Springfield, Illinois

  • Infectious Disease of Indiana

    Indianapolis, Indiana

  • Brigham & Womens Hospital

    Boston, Massachusetts

  • Site not named

    Worcester, Massachusetts

  • Upstate Infectious Diseases Association LLP

    Albany, New York

  • Regional Infection Diseases Infusion Center Inc.

    Lima, Ohio

  • University of Texas MD Anderson Cancer Center

    Houston, Texas

  • Site not named

    Buenos Aires, Argentina

  • Site not named

    Buenos Aires, Argentina

  • Site not named

    Buenos Aires, Argentina

  • Site not named

    Capital Federal, Argentina

  • Site not named

    Capital Federal, Argentina

  • Hospital Italiano de Buenos Aires

    Ciudad Autonoma, Argentina

  • Instituto Medico Especializado Alexander Fleming

    Ciudad Autonoma, Argentina

  • Site not named

    Perth, Australia

  • Mater Medical Centre

    South Brisbane, Australia

  • Site not named

    Woolloongabba, Australia

  • AZ ST Jan

    Bruges, Belgium

  • Institut Jules Bordet

    Brussels, Belgium

  • ULB Hospital Erasme

    Brussels, Belgium

  • Universitair Ziekenhuis Gent

    Ghent, Belgium

  • Universitaire Ziekenhuizen Leuven

    Leuven, Belgium

  • Felicio Rocho

    Belo Horizonte, Brazil

  • Santa Casa de Misericordia de Belo Horizonte

    Belo Horizonte, Brazil

  • Hospital das Clinicas da UFPR

    Curitiba, Brazil

  • Hospital de Clinicas da FMUSP - Ribeirao Preto

    Ribeirão Preto, Brazil

  • Hospital Universitario Clementino Fraga Filho

    Rio de Janeiro, Brazil

  • Hamilton Health Sciences - Henderson Site

    Hamilton, Canada

  • The Ottawa Hospital - General Campus

    Ottawa, Ontario, Canada

  • Site not named

    Santiago, Chile

  • Hospital Dr. Hernan Henriquez Aravena

    Temuco, Chile

  • Site not named

    Valdivia, Chile

  • 3rd Hospital, Peking University

    Beijing, China

  • The 1st Hospital, Jilin University

    Changchun, China

  • The Third Xiangya Hospital of Central South University

    Changsha, China

  • West China Hospital of Sichuan University

    Chengdu, China

Showing 40 of 107 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.